Engineers design artificial synapse for ‘brain-on-a-chip’ hardware
Researchers in the emerging field of neuromorphic computing have attempted to design computer chips that work like the human brain...
List view / Grid view
Researchers in the emerging field of neuromorphic computing have attempted to design computer chips that work like the human brain...
When you need the ultimate quality, take a look at ROMIL-UpS™ ultra lc solvents and eluants. ROMIL‑UpS™ ultra lc solvents and eluant mixes have been developed to address the challenging requirements of critical analytical applications, such as LC-MS and UHPLC, offering the utmost purity for today’s sensitive instrumentation...
The FDA has issued a Study may proceed letter for the first study in humans, thereby accepting the investigational new drug application for the drug candidate SOBI003...
A team of computer scientists have developed an algorithm that can rapidly search massive databases to discover novel variants of known antibiotics...
Engineers have created a robot that can be used to help treat babies with a rare birth defect that affects an infant's oesophagus...
Sanofi and Bioverativ Inc., have entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ...
The European Commission has granted marketing authorisation for Mvasi for the treatment of certain types of cancer...
An international research team has conducted successful phase II clinical tests of a new anti-malaria medication...
Despite providing incentives to drug manufacturers to encourage the study of medications in children, few approved drugs include safe dosing information for obese children...
Researchers have shown that the synthetically manufactured vaccine BM32 relieves the symptoms of rhinitis...
For the first time, researchers have shown that an optical fiber as thin as a human hair can be used to create microscopic structures with laser-based 3D printing.
An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of the malaria parasite that have grown resistant to one of the currently used drugs...
Previously unpublished information from the clinical trial that the FDA relied on to approve the most commonly prescribed medicine for nausea in pregnancy indicates the drug is not effective...
The FDA has approved a supplemental New Drug Application for Gilotrif for the first-line treatment of patients with metastatic non-small cell lung cancer...
Women who have gestational diabetes mellitus during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future...